2018 was a huge year for the cannabis industry. The state of California — the fifth-largest economy in the world — officially began the legal sales of adult-use cannabis. The entire country of Canada officially legalized adult-use cannabis. Mexico began the process of ending the prohibition of cannabis. All across the world, new legalization legislation was introduced, debated, and pas
You are receiving this email because you subscribed to Outsider Club.
[Click here]( to manage your e-mail preferences.
[Outsider Club logo]
6 Pot Stocks to Own for 2019
By Jeff Siegel
Written Dec. 03, 2018
2018 was a huge year for the cannabis industry.
The state of California — the fifth-largest economy in the world — officially began the legal sales of adult-use cannabis.
The entire country of Canada officially legalized adult-use cannabis.
Mexico began the process of ending the prohibition of cannabis.
All across the world, new legalization legislation was introduced, debated, and passed.
Make no mistake: The momentum behind the legalization of cannabis is a global one, and 2018 really served as the launching pad.
Cannabis investors certainly made a fortune in 2018, too.
And some of those who jumped in a few years ago — on my recommendation, and in anticipation of what we knew would happen in 2018 — became millionaires.
Of course, that’s not hard to do when Canadian cannabis stocks such as Canopy Growth Corporation (TSX: WEED), Aphria, Inc. (TSX: APH), and OrganiGram (TSX-V: OGI) all delivered gains in excess of 1,000%.
That being said, those stocks are now “old news.”
The big money has already been made in the Canadian sector, but the U.S. sector is just now starting to really heat up.
November 6th Vote Has Set the Stage to Unleash
Massive Cannabis Gains
On November 6th, Michigan voted to legalize recreational marijuana...
And this has the potential to send a group of pot stocks skyrocketing by 1,000% in very short order...
This could be the last chance for everyday Americans to get rich from marijuana.
There’s no time to waste...
[Click here to get started.](
Buy American
The U.S. cannabis market in 2019 is like the Canadian cannabis market of 2016.
Momentum is building, massive amounts of capital are moving in, and the political landscape is changing in a way that will ultimately lead to the full-scale legalization of cannabis — on a federal level.
While individual states have been the catalyst for momentum in the U.S., in 2019, we’re going to see — for the first time — a real push for legalization on the federal level.
This is the result of a number of things, including:
-
The firing of Attorney General Jeff Sessions, who was one of the most outspoken prohibitionists in Washington.
-
The replacement of Representative Pete Sessions, who was the former chairman of the House Rules Committee and the person who decided which bills made it to the House floor. Pete Sessions continually did everything in his power to keep any legalization bill from getting to the floor, where it could be properly debated and voted on. But with Sessions gone, there’s now a long list of legalization-related bills that will finally be given a fair hearing.
-
As a matter of observation, Democrats tend to be more in favor of legalization than Republicans. And with the Democrats now running the House, expect to see more legalization bills introduced — and many with bipartisan support.
-
A new wave of legalization momentum began in 2018 in a number of key states, including New York, Illinois, New Mexico, New Jersey, and Connecticut. If these five states are successful at initiating some kind of adult-use cannabis legalization in 2019, it would put more pressure on the federal government to lift the prohibition on cannabis.
[$50 Into $1,200,000](
If you had put $50 into Pfizer stock at its IPO, you’d be a millionaire. You’re about to discover the “Next Pfizer”, which recently IPO’d.
I’ve visited restricted areas of this company and grilled the CEO personally. This company is disrupting a $635 billion industry.
And it trades for a couple bucks...
Here’s your shot to 10X your money. [Click here to see the company.](
Cannabis: The Millionaire-Maker
Now that legalization is in place in Canada, members of my Green Chip Stocks community have taken their massive winnings off the table and have begun to re-allocate that capital into the U.S. market.
While there’s still plenty of money to be made in the Canadian cannabis space, you’re simply just going to get more bang for your buck in the U.S. cannabis market in 2019. And that’s where we’re now focused.
Some of the U.S. cannabis stocks that we expect to absolutely crush it in 2019 include, but are not limited to:
- Innovative Industrial Properties (NYSE: IIPR)
- Curaleaf Holdings (OTCBB: CURLF)
- Liberty Health Sciences (OTCBB: LHSIF)
- iAnthus (OTCBB: ITHUF)
- MariMed (OTCBB: MRMD)
- Acreage Holdings (OTCBB: ACRZF)
And in addition to the U.S., there are other opportunities outside of North America.
Elixinol (OTCBB: ELLXF) has some pretty nice exposure to Australia, and Khiron Life Sciences (OTCBB: KHRNF) is a good choice in Latin America. The latter is quite impressive, boasting the former president of Mexico, Vicente Fox, on its board.
Of course, the cannabis industry has been rapidly evolving over the past few years, and 2019 will be no different.
So if you’re looking to capitalize on this continued growth, I strongly urge you to [become a member of Green Chip Stocks](, where I send out weekly updates on the cannabis industry, as well as new stock picks.
You can also learn how I uncovered some of my biggest winners in the space by [clicking here](.
Some of those big winners that we closed out in 2018 include:
- Aphria, Inc. (TSX: APH) — 1,174.3% gain
- OrganiGram (TSX-V: OGI) — 1,185% gain
- Canopy Growth Corporation (TSX: WEED) — 3,015.6% gain
Members of my community who invested just $25K in Canopy Growth Corporation when I first made the recommendation turned that initial investment into nearly $800,000.
Double up to $50K, and that was an easy $1.5 million.
From one stock!
That ain’t chump change.
And make no mistake: What we already did in Canada cannabis stocks, we’re about to do again in U.S. cannabis stocks.
[Click here]( to join us now.
To a new way of life and a new generation of wealth...
[Jeff Siegel Signature]
Jeff Siegel
[[follow basic]@JeffSiegel on Twitter](
Jeff is the founder and managing editor of Green Chip Stocks, a private investment community that capitalizes on opportunities in alternative energy, organic food markets, legal cannabis, and socially responsible investing. He has been a featured guest on Fox, CNBC, and Bloomberg Asia, and is the author of the best-selling book, Investing in Renewable Energy: Making Money on Green Chip Stocks. For more on Jeff, go to his editor's [page](.
[The Medical Equivalent of Gold](
This rare fluid is worth $60,000 a gallon: [blue_blood_190x190]
Without its strange powers, Big Pharma would completely go out of business.
One small company has quietly cornered the market on this substance, soaking up 90% of the world's supply.
You could ride it for 10,000% gains.
[Find out how.](
Enjoy reading this article? [Click here]( to like it and receive similar articles to read!
Browse Our Archives
[Living Legend James Dines: A Situation Right Up Our Alley](
[Scooby Doo: An American Hero](
[Dining with the Cannibals](
[Unicorns Exist!](
[The 2019 Tech Outlook](
---------------------------------------------------------------
This email was sent to {EMAIL}. It is not our intention to send email to anyone who doesn't want it. If you're not sure why you've received this e-letter, or no longer wish to receive it, you may [unsubscribe here](, and view our privacy policy and information on how to manage your subscription.
To ensure that you receive future issues of Outsider Club, please add newsletter@outsiderclub.com to your address book or whitelist within your spam settings. For customer service questions or issues, please contact us for assistance.
[Outsider Club](, Copyright © 2018, [Angel Publishing LLC]( & Outsider Club LLC, 111 Market Place #720, Baltimore, MD 21202. For Customer Service, please call (877) 303-4529. All rights reserved. [View our privacy policy here.]( No statement or expression of opinion, or any other matter herein, directly or indirectly, is an offer or the solicitation of an offer to buy or sell the securities or financial instruments mentioned. Angel Publishing and Outsider Club does not provide individual investment counseling, act as an investment advisor, or individually advocate the purchase or sale of any security or investment. Subscribers should not view this publication as offering personalized legal or investment counseling. Investments recommended in this publication should be made only after consulting with your investment advisor and only after reviewing the prospectus or financial statements of the company in question. This letter is not intended to meet your specific individual investment needs and it is not tailored to your personal financial situation. Nothing contained herein constitutes, is intended, or deemed to be – either implied or otherwise – investment advice. Neither the publisher nor the editors are registered investment advisors. This letter reflects the personal views and opinions of Nick Hodge and that is all it purports to be. While the information herein is believed to be accurate and reliable it is not guaranteed or implied to be so. Neither Nick Hodge, nor anyone else, accepts any responsibility, or assumes any liability, whatsoever, for any direct, indirect or consequential loss arising from the use of the information in this letter. The information contained herein is subject to change without notice, may become outdated and may not be updated. Nick Hodge, entities that he controls, family, friends, employees, associates, and others may have positions in securities mentioned, or discussed, in this letter. No part of this letter/article may be reproduced, copied, emailed, faxed, or distributed (in any form) without the express written permission of Nick Hodge or the Outsider Club. Unauthorized reproduction of this newsletter or its contents by Xerography, facsimile, or any other means is illegal and punishable by law.